Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder, Mixed”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Post-approval studies (Phase 4)Study completedNCT00402324
What this trial is testing

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Who this might be right for
Bipolar I Disorder
Eli Lilly and Company 202
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Post-approval studies (Phase 4)Study completedNCT01195363
What this trial is testing

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

Who this might be right for
Bipolar Disorder
The University of Texas Health Science Center at San Antonio 28
Not applicableStudy completedNCT02507349
What this trial is testing

Person-Centered Versus Measurement-Based Care in Mental Health

Who this might be right for
SchizophreniaBipolar DisorderMajor Depression
University of Pittsburgh 2,443
Not applicableStudy completedNCT05965232
What this trial is testing

FIbrosis and Steatosis in Patients With Psychiatric Illness

Who this might be right for
Severe Bipolar I Disorder (Diagnosis)Bipolar I Disorder, Most Recent Episode Mixed, in RemissionDepression Psychotic Feature+1 more
Centre Hospitalier Esquirol 385
Large-scale testing (Phase 3)Study completedNCT00271258
What this trial is testing

Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents

Who this might be right for
Bipolar Disorder
Sanofi 200
Large-scale testing (Phase 3)Study completedNCT00266630
What this trial is testing

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Manic or Mixed Episode Associated With Bipolar I Disorder
Eli Lilly and Company 139
Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Testing effectiveness (Phase 2)Study completedNCT00206778
What this trial is testing

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

Who this might be right for
Mixed Mania Bipolar Disorder
Beth Israel Medical Center 36
Post-approval studies (Phase 4)Study completedNCT00643123
What this trial is testing

Allopurinol Add-on Treatment for Refractory Mania

Who this might be right for
Bipolar DisorderMixed ManiaTreatment-Resistant Mania
Cedars-Sinai Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Large-scale testing (Phase 3)Looking for participantsNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Study completedNCT00129220
What this trial is testing

Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 224
Large-scale testing (Phase 3)Study completedNCT00035230
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Post-approval studies (Phase 4)Study completedNCT02870283
What this trial is testing

Cost- Effectiveness and Quality of Life Assessment in Mood Disorder

Who this might be right for
Bipolar Disorder
Federal University of Rio Grande do Sul 107
Load More Results